| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 0 | 2.801 | 583 | 813 | 706 | 2.039 | 1.681 |
| Total Income - EUR | - | - | - | 0 | 2.801 | 583 | 813 | 706 | 2.039 | 1.681 |
| Total Expenses - EUR | - | - | - | 3.956 | 948 | 2.440 | 3.929 | 335 | 2.537 | 2.412 |
| Gross Profit/Loss - EUR | - | - | - | -3.956 | 1.853 | -1.857 | -3.117 | 370 | -498 | -732 |
| Net Profit/Loss - EUR | - | - | - | -3.956 | 1.769 | -1.875 | -3.125 | 349 | -498 | -732 |
| Employees | - | - | - | 1 | 0 | 1 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Toccoderm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | - | - | 43 | 42 | 500 | 40 | 41 | 40 | 0 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash | - | - | - | 43 | 42 | 500 | 40 | 41 | 40 | 0 |
| Shareholders Funds | - | - | - | -3.913 | -2.068 | -3.904 | -6.942 | -6.615 | -7.093 | -7.785 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 3.956 | 2.110 | 4.404 | 6.983 | 6.655 | 7.134 | 7.785 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "9604 - 9604" | |||||||||
| CAEN Financial Year |
9604
|
|||||||||
Comments - Toccoderm Srl